A look ahead at this week in women's health from Contemporary OB/GYN:
At ACR Convergence 2022, Hyun Son, PharmD, discussed the role of the FDA’s Drug Shortage Staff in preventing and mitigating drug shortages.
Cleveland Clinic begins charging for doctors’ time spent responding to some electronic messages
At ACR Convergence 2022, Amit Golding, MD, PhD, outlined drugs recently approved by the FDA, and discussed the requirements for biosimilars to meet approval.
Exposure to more than 100 mg was linked to significantly lower odds ratios for first-ever ACS event for women.
The association between type of body composition and fibromyalgia was evaluated using 43 women with clinically diagnosed fibromyalgia.
Check back soon for additional updates.
Gender discrepancy found in ABCA4-associated retinopathy
April 18th 2024A recent meta-analysis suggests sex as a modifying factor in the development of ABCA4-associated retinopathy, revealing a higher proportion of women among individuals with a mild reduced penetrant ABCA4 variant, impacting prognosis predictions and recurrence risks.
Read More